(Q40122869)

17 September 2017

1 reference

title

Adenosine deaminase deficiency and severe combined immunodeficiency disease (English)

1 reference

17 September 2017

Adenosine Deaminase Deficiency and Severe Combined Immunodeficiency Disease (English)

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

severe combined immunodeficiency

8 September 2023

main subject

1 reference

based on heuristic

inferred from title

adenosine deaminase deficiency

1 reference

L. F. Thompson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6255772

8 September 2023

J. E. Seegmiller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6255772

8 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6255772

8 September 2023

publication date

1 January 1980

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9780470122969.ch4

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

https://onlinelibrary.wiley.com/doi/pdf/10.1002/9780470122969.ch4

8 September 2023

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Advances in Enzymology and Related Areas of Molecular Biology

8 September 2023

published in

1 reference

17 September 2017

51

1 reference

17 September 2017

167-210

1 reference

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine-deaminase deficiency and combined immunodeficiency syndrome

8 September 2023

3

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency

8 September 2023

4

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973

8 September 2023

5

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of chromosome 6

8 September 2023

6

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6

8 September 2023

7

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity

8 September 2023

8

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine deaminase deficiency: Frequency and comparative pathology in autosomally recessive severe combined immunodeficiency

8 September 2023

16

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Immune deficiency: evaluation, diagnosis, and therapy.

8 September 2023

22

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Hereditary Severe Combined Immunodeficiency and Adenosine Deaminase Deficiency

8 September 2023

23

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme

8 September 2023

25

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deficiency of adenosine deaminase not associated with severe combined immunodeficiency

8 September 2023

26

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Red cell adenosine deaminase (ADA) polymorphism in Southern Africa, with special reference to ADA deficiency among the !Kung

8 September 2023

28

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Red-blood-cell adenosine deaminase deficiency in a "healthy" Kung individual

8 September 2023

29

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Detection of the Carrier State in Combined Immunodeficiency Disease Associated with Adenosine Deaminase Deficiency

8 September 2023

31

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Evidence for Control of Several Different Tissue-specific Isozymes of Adenosine Deaminase by a le Genetic Locus

8 September 2023

32

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine-deaminase deficiency in a child diagnosed prenatally

8 September 2023

33

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency

8 September 2023

36

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease

8 September 2023

40

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency

8 September 2023

41

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency

8 September 2023

42

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purine Metabolism in Adenosine Deaminase Deficiency

8 September 2023

44

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purine metabolism in adenosine deaminase deficiency.

8 September 2023

47

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Increased purine nucleotides in adenosinedeaminase-deficient lymphocytes

8 September 2023

49

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(s)

8 September 2023

55

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency

8 September 2023

56

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine deaminase isozymes in human tissues

8 September 2023

57

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Alterations in isozymes of adenosine deaminase during stimulation of human peripheral blood lymphocytes.

8 September 2023

58

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The investigation of reactive sulphydryls in enzymes and their variants by starch gel electrophoresis. Studies on red cell adenosine deaminase

8 September 2023

59

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Tissue-characteristic forms of adenosine deaminase

8 September 2023

60

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Multiple forms of human adenosine deaminase. I. Purification and characterization of two molecular species

8 September 2023

61

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Partial purification and properties of the common inherited forms of adenosine deaminase from human erythrocytes

8 September 2023

62

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme

8 September 2023

65

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Multiple forms of human adenosine deaminase. II. Isolation and properties of a conversion factor from human lung

8 September 2023

66

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Conversion of human erythrocyte-adenosine deaminase activity to different tissue-specific isozymes. Evidence for a common catalytic unit

8 September 2023

67

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine Deaminase: Characterization of the Molecular Heterogeneity of the Enzyme in Human Tissue

8 September 2023

68

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine deaminase from human erythrocytes: Purification and effects of adenosine analogs

8 September 2023

69

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

A general method of purification of adenosine deaminase by affinity chromatography

8 September 2023

70

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purification of human erythrocyte adenosine deaminase

8 September 2023

73

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Human Adenosine Deaminase: Stoichiometry of the Large form Complex

8 September 2023

79

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Radioimmunochemical Analysis of Human Erythrocyte Adenosine Deaminase

8 September 2023

81

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Molecular form of adenosine deaminase in severe combined immunodeficiency

8 September 2023

83

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency

8 September 2023

85

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase

8 September 2023

86

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs

8 September 2023

87

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency

8 September 2023

88

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The function of adenosine deaminase in the human erythrocyte

8 September 2023

89

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase.

8 September 2023

91

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Studies of the Regulation of Purine Nucleotide Catabolism

8 September 2023

92

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines

8 September 2023

94

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors

8 September 2023

95

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Structure of coformycin, an unusual nucleoside of microbial origin

8 September 2023

97

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin

8 September 2023

98

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine)

8 September 2023

99

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells

8 September 2023

100

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin

8 September 2023

102

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin

8 September 2023

103

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Specificity of adenosine deaminase inhibitors

8 September 2023

104

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Mutants of Chinese hamster cells resistant to adenosine

8 September 2023

106

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deoxyribonucleoside triphosphate pools and adenosine toxicity

8 September 2023

107

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine metabolism in cultured lymphoid cells

8 September 2023

108

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The adenosine-like effect of exogenous cyclic AMP upon nucleotide and PP-ribose-P concentrations of cultured human lymphoblasts

8 September 2023

109

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purine toxicity in human lymphoblasts

8 September 2023

110

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

8 September 2023

111

38

2357

Snyder F. F.

1978

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease

8 September 2023

112

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Analysis of adenosine-mediated pyrimidine starvation using cultured wild-type and mutant mouse T-lymphoma cells

8 September 2023

113

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenine and Adenosine Are Toxic to Human Lymphoblast Mutants Defective in Purine Salvage Enzymes

8 September 2023

114

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Inhibition of the synthesis of 5-phosphoribosyl-1-pyrophosphate by 3'-deoxy-adenosine and structurally related nucleoside analogs

8 September 2023

115

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes

8 September 2023

118

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis

8 September 2023

119

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine and Guanosine Metabolism During Phytohemagglutinin Induced Transformation of Human Lymphocytes

8 September 2023

120

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine

8 September 2023

122

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation.

8 September 2023

123

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin

8 September 2023

124

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase

8 September 2023

125

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Modulation of inflammation and immunity by cyclic AMP.

8 September 2023

127

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

8 September 2023

Molecular Pharmacology

129

6

13

Sattin A.

1970

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets

8 September 2023

130

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Cyclic 3',5'-adenosine monophosphate in isolated bone cells. II. Responses to adenosine and parathyroid hormone

8 September 2023

131

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine-mediated elevation of cyclic 3':5'-adenosine monophosphate concentrations in cultured mouse neuroblastoma cells

8 September 2023

133

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine Inhibition of Lymphocyte-Mediated Cytolysis: Possible Role of Cyclic Adenosine Monophosphate

8 September 2023

135

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Inhibition of lymphocyte-mediated cytolysis by adenosine analogs. Biochemical studies concerning mechanism of action

8 September 2023

136

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism

8 September 2023

138

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Control of deoxyribonucleotide synthesis in vitro and in vivo

8 September 2023

140

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

On the effect of some adenine derivatives on the incorporation in vitro of isotopically labelled compounds into the nucleic acids of Ehrlich ascites tumor cells

8 September 2023

141

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Further studies on the inhibition of nucleic acid biosynthesis by azathymidine and by deoxyadenosine

8 September 2023

142

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Formation in vitro of deoxyadenosine triphosphate from deoxyadenosine in Ehrlich ascites cells

8 September 2023

143

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The effect of some purine deoxyribosides on the incorporation of [14C] formate and [32P] orthophosphate into DNA of ascites tumor cells in vitro

8 September 2023

144

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

On the mechanism of inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells by deoxyadenosine in vitro

8 September 2023

145

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Biochimica et Biophysica Acta

8 September 2023

146

61

885

Klenow H.

1962

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Decreased DNA synthesis in mammalian cells after exposure to deoxyadenosine

8 September 2023

148

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes

8 September 2023

149

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease

8 September 2023

150

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells

8 September 2023

151

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Molecular Mechanism(s) of Deoxyribonucleoside Toxicity in T-Lymphoblasts

8 September 2023

155

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts

8 September 2023

156

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines

8 September 2023

160

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase

8 September 2023

161

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Possible Role for 5′-Nucleotidase in Deoxyadenosine Selective Toxicity to Cultured Human Lymphoblasts

8 September 2023

162

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cells

8 September 2023

165

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Studies on inhibitors of mammalian tRNA methylases

8 September 2023

168

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

[Inhibition of a t-RNA N 2 -guanine methyl transferase from rabbit liver by analogs of S-adenosyl homocysteine]

8 September 2023

170

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

S-Adenosylhomocysteine inhibition of three purified tRNA methyltransferases from rat liver

8 September 2023

172

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: Evidence for a methylation reaction essential to cytolysis

8 September 2023

174

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

S -Adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin

8 September 2023

176

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

S-adenosylhomocysteine hydrolase is an adenosine-binding protein: a target for adenosine toxicity

8 September 2023

179

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients

8 September 2023

182

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Severe Combined Immunodeficiency and Adenosine Deaminase Deficiency

8 September 2023

183

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease

8 September 2023

184

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation

8 September 2023

185

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Successful fetal liver transplantation in a child with severe combined immunodeficiency

8 September 2023

187

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency

8 September 2023

188

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

In Vivo and in Vitro Effects of Thymosin and Adenosine Deaminase on Adenosine-Deaminase-Deficient Lymphocytes

8 September 2023

189

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency

8 September 2023

190

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency

8 September 2023

192

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Perfusion damage to renal allografts

8 September 2023

199

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Inhibition for Immunosuppression

8 September 2023

200

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Inhibition of maturation of human precursor lymphocytes by coformycin, and inhibitor of the enzyme adenosine deaminase

8 September 2023

202

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

In Vitro and in Vivo Effect of Deoxycoformycin in Human T Cell Leukemia

8 September 2023

203

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Biochemical Consequences of Treatment with the Adenosine Deaminase Inhibitor 2′-Deoxycoformycin

8 September 2023

204

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Treatment of Acute Lymphoblastic Leukemia with the Adenosine Deaminase Inhibitor 2′-Deoxycoformycin

8 September 2023

205

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

8 September 2023

206

35

1547

Plunkett W.

1975

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

8 September 2023

207

36

1481

LePage G. A.

1976

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase Deficiency

8 September 2023

210

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deoxyguanosine toxicity in a mouse T lymphoma: Relationship to purine nucleoside phosphorylase-associated immune dysfunction

8 September 2023

211

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiency

8 September 2023

212

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: Genetic model for immunodeficiency disease

8 September 2023

213

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Lymphocyte Ecto-5′-Nucleotidase Deficiency in Agammaglobulinemia

8 September 2023

214

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia

8 September 2023

216

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

Distribution of 5'-nucleotidase in human lymphoid tissues

8 September 2023

220

1 reference

https://api.crossref.org/works/10.1002/9780470122969.CH4

8 September 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6255772

8 September 2023

1 reference